Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioassay design and MTD setting: old methods and new approaches

J A Swenberg1

  • 1Department of Environmental Science and Engineering, University of North Carolina, Chapel Hill 27599, USA.

Regulatory Toxicology and Pharmacology : RTP
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions.

Environmental and molecular mutagenesis·2018
Same author

Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Cancer chemotherapy and pharmacology·2011
Same author

Health effects of subchronic inhalation exposure to gasoline engine exhaust.

Inhalation toxicology·2008
Same author

Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.

Regulatory toxicology and pharmacology : RTP·2008
Same author

Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate.

Kidney international·2006
Same author

Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.

Carcinogenesis·2005

Designing carcinogenicity bioassays requires careful consideration of scientific factors. New methods improve dose setting and data interpretation for better human risk extrapolation from animal studies.

Area of Science:

  • Toxicology and Carcinogenesis
  • Biostatistics
  • Risk Assessment

Background:

  • Carcinogenicity bioassays are essential for evaluating chemical safety.
  • Interpreting bioassay data relies heavily on proper experimental design.
  • Current default assumptions in risk assessment can be improved.

Purpose of the Study:

  • To explore the scientific principles for designing effective carcinogenicity bioassays.
  • To discuss novel approaches for optimizing dose selection and result interpretation.
  • To enhance the accuracy of extrapolating animal study findings to human health risks.

Main Methods:

  • Review of scientific underpinnings for bioassay design.
  • Exploration of new methodologies for dose setting.

Related Experiment Videos

  • Analysis of factors influencing dose-response curve shape.

    • Main Results:

    • Key factors determining dose-response include molecular DNA dose, cell proliferation, and cell death.
    • New approaches can refine dose setting and interpretation of bioassay outcomes.
    • Data on molecular and cellular events can replace default assumptions.

    Conclusions:

    • Improved bioassay design enhances data reliability and utility.
    • Utilizing molecular and cellular data improves the extrapolation of animal carcinogenicity findings to humans.
    • This approach leads to more accurate human health risk assessments.